ATBECHDE..ESFRGB..ITLILUNLSE........................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0449871A119911009EP90900264.01989121319910611enenen1988028450219881214US1991100919914119911009199141

G01N 33/ 00 A I

A61K 31/ 535 A I

A61K 31/ 5375 A I

A61K 31/ 545 A I

A61K 31/ 546 A I

A61K 31/ 55 A I

A61K 31/ 554 A I

A61P 31/ 04 A I

C07B 61/ 00 A I

C07D 223/ 06 A I

C07D 241/ 06 A I

C07D 265/ 30 A I

C07D 267/ 08 A I

C07D 273/ 06 A I

C07D 279/ 12 A I

C07D 285/ 36 A I

C07D 501/ 00 A I

C07K 1/ 00 A I

C07K 7/ 06 A I

G01N 33/ 15 A I

enMETHOD FOR PREDICTING BIOLOGICAL ACTIVITY OF ANTIBIOTICS, AND NOVEL NON BETA-LACTAM ANTIBACTERIAL AGENTS DERIVED THEREFROMfrPROCEDE DE PREDICTION D'ACTIVITE D'ANTIBIOTIQUES ET NOUVEAUX AGENTS ANTIBACTERIENS NON BETA-LACTAME DERIVES DE CEUX-CIdeMETHODE ZUM VORAUSSAGEN DER BIOLOGISCHEN AKTIVITÄT SOWIE DAVON HERGELEITETE NEUE BETA-LACTAMENHICKS, RichardFairfields, Magpie Hall LaneStubbs Cross, Ashford, KentGBQUEENS UNIVERSITYKingston Ontario K7L 3N6CAWOLFE, SaulR.R. 1Kingston, Ontario K7L 4V1CABRUDER, Stephen22 Wagner StreetGlenburnie, Ontaria K0H 1S0CACopp, David ChristopherDummett Copp & Co. 25 The Square Martlesham HeathIpswich Suffolk IP5 7SLGBATBECHDEESFRGBITLILUNLSEGB198900149319891213enWO199000711119900628199015